Package 70518-4218-0

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 70518-4218-0
Digits Only 7051842180
Product NDC 70518-4218
Description

30 TABLET, FILM COATED in 1 BLISTER PACK (70518-4218-0)

Marketing

Marketing Status
Marketed Since 2024-10-21
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (0)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "47e30df7-831d-2c9d-e063-6294a90a8266", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993687"], "spl_set_id": ["990587bd-4c7d-4a36-8a38-3104648ab3a2"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (70518-4218-0)", "package_ndc": "70518-4218-0", "marketing_start_date": "20241021"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-4218-1)", "package_ndc": "70518-4218-1", "marketing_start_date": "20260108"}], "brand_name": "Bupropion Hydrochloride", "product_id": "70518-4218_47e30df7-831d-2c9d-e063-6294a90a8266", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70518-4218", "generic_name": "Bupropion Hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA203013", "marketing_category": "ANDA", "marketing_start_date": "20241021", "listing_expiration_date": "20271231"}